Jul. 4—MORGANTOWN — The tangled world of generic pharmaceuticals took another twist last week, as Mylan Pharmaceuticals filed suit in federal court against Israel-based Teva, alleging Teva illegally ...

Teva Pharmaceutical is facing down plenty of lawsuits. Now, one of its chief rivals in the generics field is adding another case to Teva's plate. Mylan, which has merged with Pfizer's Upjohn to form ...

The FINANCIAL — Teva Pharmaceutical Industries Ltd. on April 21 announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $82.00 per Mylan ...

Teva Pharmaceutical says rival generic drugmaker Mylan is engaging in a “desperate attempt” to keep its board and shareholders from considering Teva’s $40 billion-plus takeover offer. The claim, ...

June 13 (Reuters) - Mylan Nv: * Mylan's letter to shareholders dated june 12 says Teva’s expression of interest was simply not right for Mylan and its stakeholders * Mylan - despite Mylan’s leadership ...

Oct 16 (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd sued rival Mylan Inc , alleging that Mylan's application to market a copycat version of Teva's multiple sclerosis drug Copaxone ...

Mylan has rejected Teva’s unsolicited bid. Robert J. Coury, Mylan’s executive chairman, said Teva’s roughly $40 billion offer grossly undervalues the company and “would require Mylan’s shareholders to ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

We strongly disagree with the stated analysis of Stichting Preferred Shares Mylan and its decision to exercise its call option, which is unwarranted, relies on false assumptions, and risks depriving ...

JERUSALEM-- (BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has withdrawn its cash and stock proposal to acquire all of the outstanding ordinary ...

David Beard, The Dominion Post, Morgantown, W.Va. July 4, 2021 at 10:32 PM Jul. 4—MORGANTOWN — The tangled world of generic pharmaceuticals took another twist last week, as Mylan Pharmaceuticals filed ...